Compare KFFB & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KFFB | ABVC |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7M | 34.6M |
| IPO Year | 2004 | 2009 |
| Metric | KFFB | ABVC |
|---|---|---|
| Price | $4.79 | $1.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.3K | ★ 120.6K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.52 | 7.14 |
| EPS | ★ 0.15 | N/A |
| Revenue | $15,000.00 | ★ $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.93 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.51 | $0.88 |
| 52 Week High | $4.98 | $4.02 |
| Indicator | KFFB | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 46.18 |
| Support Level | $4.26 | $1.18 |
| Resistance Level | $4.86 | $1.47 |
| Average True Range (ATR) | 0.11 | 0.13 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 83.87 | 17.42 |
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.